Energenesis Biomedical (Taiwan) Probability of Future Stock Price Finishing Over 59.00
6657 Stock | 59.00 1.40 2.43% |
Energenesis |
Energenesis Biomedical Target Price Odds to finish over 59.00
The tendency of Energenesis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
59.00 | 90 days | 59.00 | near 1 |
Based on a normal probability distribution, the odds of Energenesis Biomedical to move above the current price in 90 days from now is near 1 (This Energenesis Biomedical Co probability density function shows the probability of Energenesis Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Energenesis Biomedical has a beta of 0.32. This suggests as returns on the market go up, Energenesis Biomedical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Energenesis Biomedical Co will be expected to be much smaller as well. Additionally Energenesis Biomedical Co has an alpha of 0.1084, implying that it can generate a 0.11 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Energenesis Biomedical Price Density |
Price |
Predictive Modules for Energenesis Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Energenesis Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Energenesis Biomedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Energenesis Biomedical is not an exception. The market had few large corrections towards the Energenesis Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Energenesis Biomedical Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Energenesis Biomedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.11 | |
β | Beta against Dow Jones | 0.32 | |
σ | Overall volatility | 2.15 | |
Ir | Information ratio | 0.03 |
Energenesis Biomedical Technical Analysis
Energenesis Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Energenesis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Energenesis Biomedical Co. In general, you should focus on analyzing Energenesis Stock price patterns and their correlations with different microeconomic environments and drivers.
Energenesis Biomedical Predictive Forecast Models
Energenesis Biomedical's time-series forecasting models is one of many Energenesis Biomedical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Energenesis Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Energenesis Biomedical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Energenesis Biomedical's short interest history, or implied volatility extrapolated from Energenesis Biomedical options trading.
Additional Tools for Energenesis Stock Analysis
When running Energenesis Biomedical's price analysis, check to measure Energenesis Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Energenesis Biomedical is operating at the current time. Most of Energenesis Biomedical's value examination focuses on studying past and present price action to predict the probability of Energenesis Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Energenesis Biomedical's price. Additionally, you may evaluate how the addition of Energenesis Biomedical to your portfolios can decrease your overall portfolio volatility.